Critical Care Medicine

Hospital-Acquired Infections

The goal of the Respiratory Institute is zero hospital-acquired infections. The institute’s quality team leads a multidisciplinary process to analyze and refine patient care to achieve that goal. Despite the COVID-19 pandemic, there was a decrease in MICU central line-associated bloodstream infections (CLABSI) in 2021.

MICU Central Line-Associated Bloodstream Infection Rates

2019 – 2021

CLABSI = central line-associated bloodstream infection, MICU = Medical Intensive Care Unit, SIR = standard infection ratio

​

​

The rate of CLABSI increased during 2020 likely related to the COVID-19 pandemic. Interventions to address the rise in infections led to a decrease in CLABSI in 2021. The MICU team continues to work to minimize the risk of hospital-acquired infections.

MICU Catheter-Associated Urinary Tract Infection (SIR)

2019 – 2021

CAUTI = catheter-associated urinary tract infection, MICU = Medical Intensive Care Unit, SIR = standard infection ratio

​

The number of catheter-associated urinary tract infections (CAUTI) remains well below the 1.0 SIR predicted target. The MICU’s aim is to reduce the risk of CAUTI by maintaining CAUTI prevention best practices.